Cyr61 Regulates Bmp-2-Dependent Osteoblast Differentiation through the Alpha(V)Beta(3) Integrin/Integrin-Linked Kinase/Erk Pathway

Osteoporosis is one of the most common bone pathologies. A number of novel molecules have been reported to increase bone formation including cysteine-rich protein 61 (CYR61), a ligand of integrin receptor, but mechanisms remain unclear. It is known that bone morphogenetic proteins ( BMPs), especially BMP-2, are crucial regulators of osteogenesis. However, the interaction between CYR61 and BMP-2 is unclear. We found that CYR61 significantly increases proliferation and osteoblastic differentiation in MC3T3-E1 osteoblasts and primary cultured osteoblasts. CYR61 enhances mRNA and protein expression of BMP-2 in a time-and dose-dependent manner. Moreover, CYR61-mediated proliferation and osteoblastic differentiation are significantly decreased by knockdown of BMP-2 expression or inhibition of BMP-2 activity. In this study we found integrin alpha(v)beta(3) is critical for CYR61-mediated BMP-2 expression and osteoblastic differentiation. We also found that integrin- linked kinase, which is downstream of the alpha(v)beta(3) receptor, is involved in CYR61-induced BMP-2 expression and subsequent osteoblastic differentiation through an ERK- dependent pathway. Taken together, our results show that CYR 61 up- regulates BMP-2mRNA and protein expression, resulting in enhanced cell proliferation and osteoblastic differentiation through activation of the alpha(v)beta(3) integrin/integrin-linked kinase/ERK signaling pathway